All Tests, General Health, Annual Wellness, Limited Time Offers, Men’s Health, Health & Wellness
Man discusses prostate cancer screening with healthcare provider.

PSA Prostate Cancer Screening Test

-
$ 69.0
$69

Also pay with

Are you concerned about prostate cancer? Consider getting a PSA screening.

All men are at risk for prostate cancer—you have the option be proactive.  


More than 10% of men in the U.S. develop prostate cancer in their lifetime.¹ Our PSA (prostate-specific antigen) Prostate Cancer Screening Test measures the level of prostate-specific antigen in your blood. Knowing your PSA number can help you and your healthcare provider figure out if further testing or treatment should be considered because an elevated PSA may be a sign of prostate cancer.  
 
Age is the most common risk factor—the older you are, the greater the chance is of having prostate cancer. Many men with prostate cancer don’t show early symptoms and may not even know they have the disease.²
  
Note: This test does not indicate whether or not you have prostate cancer—but it gives proactive insight into your overall prostate health, which could lead to earlier diagnosis and better outcomes in some men with the disease.¹ This test is not intended for those who have undergone prostatectomy or those who have known prostate conditions. Talk to your healthcare provider to discuss if the PSA screening test is right for you. See below and in the FAQs for guideline recommendations and the benefits/risks of PSA screening. 

PSA Prostate Cancer Screening Test
$ 69.0
$69

Test Details

blood sample icon
Sample Type: Blood
building icon
Collection Method: In person at a Labcorp location
number icon
Age: 18+
laptop icon
Results: 1-2 days from when your sample arrives at our lab
note icon
HSA/FSA: Accepted
intended user icon
Test must be taken by purchaser

Preparation: No special preparation needed.

What's Tested
  • Prostate Specific Antigen (PSA)

    A protein produced by both healthy and cancerous cells in the prostate gland.

FAQ

  • The prostate is a small gland that plays a major role in your reproductive function. It produces prostatic fluid, which prolongs the lifespan of sperm and contributes to the volume of semen.

  • Major medical associations and societies, including the US Preventive Services Task Force, American Cancer Society, American Urological Association, agree that men should discuss screening with their health care providers. They also agree that men should be informed about the benefits and risks of prostate cancer screening and treatment and make decisions that best reflect personal values and preferences.⁹

     

    According to the American Cancer Society (ACS), the discussion about screening should take place at:

      

    • Age 50 for men who are at average risk of prostate cancer and are expected to live at least 10 more years.

    • Age 45 for men at high risk of developing prostate cancer. This includes African Americans and men who have a first-degree relative (father or brother) diagnosed with prostate cancer at an early age (younger than age 65).

    • Age 40 for men at even higher risk (those with more than one first-degree relative who had prostate cancer at an early age).⁵

  • Screening can provide earlier detection of prostate cancer which could provide the opportunity for more treatment options and better survival odds in some men, but there are also potential risks associated with screening, diagnosis and treatment that should be considered. Possible risks may include false positive results, overdiagnosis of prostate cancer and potential complications from prostate cancer treatment. Detection and treatment of a slow-growing prostate cancer that may have never caused symptoms in the patient’s lifetime can result in complications from the treatment, but no benefit, referred to as overdiagnosis.¹

  • Yes to both. A false negative result is possible (normal PSA level when in fact the person has prostate cancer). Patients taking certain medications, including finasteride (a.k.a. Propecia) and dutasteride (a.k.a. Avodart) may have a falsely lower PSA level.

     

    A false positive result is possible (elevated PSA level when in fact the person does not have prostate cancer). False positive results may cause patients to worry unnecessarily and may lead to unnecessary additional testing and treatment, so it’s important to be aware of this possibility. Older men are more likely to have false positive results because PSA levels increase with age in otherwise healthy men.⁸ Common benign conditions such as benign prostatic hyperplasia (BPH) can also result in a false positive result. 

     

    As with any kind of screening or testing, you should share and discuss your test results with your healthcare provider.

  • High levels of PSA may be a sign of prostate cancer. Although this test does contribute to early diagnosis of men with prostate cancer, an elevated PSA test alone does not always indicate cancer. Benign conditions, such as benign prostatic hyperplasia (BPH) and prostatitis, often elevate PSA levels. Furthermore, BPH is much more common than prostate cancer, affecting nearly 70% of men in their 60’s.¹ Older men are more likely to have false positive results (i.e., high PSAs in the absence of cancer) because PSA levels increase with age in otherwise healthy men.²  In some studies, men over 50 with mildly elevated PSAs (4.0 – 10.0 ng/mL) only had a 25% probability of having prostate cancer on biopsy.³

     

    As with any kind of screening or testing, you should share and discuss your test results with your healthcare provider who can help you interpret an abnormal result and determine if further evaluation is indicated.

  • Your testing will be performed in a CLIA-certified clinical laboratory. Labcorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. Our labs perform regular quality assurance testing to ensure our results are accurate.

  • Your results will be provided to you through our secure online portal to view or print. Results are also made available through a secure portal to the independent healthcare provider who placed your test order.  If you are accessing your results through your Labcorp Patient™ account, all users linked to the account will have access to all OnDemand test results. Results may also be provided to a local, state, and/or federal health authority; for example, many states require the testing laboratory and physician to report test results for certain communicable diseases, such as COVID-19, to local or state health departments.

     

    If you have questions or comments regarding the Labcorp Notice of Privacy Practices, or have a complaint about our use or disclosure of your PHI or our privacy practices, please contact: privacyofficer@labcorp.com, call us at (877) 234-4722 (877-23-HIPAA) and ask for the Labcorp HIPAA Privacy Officer, or send a written request to: HIPAA Privacy Officer, Labcorp, 531 South Spring Street, Burlington, NC 27215. You also may file a complaint with the Secretary of the U.S. Department of Health and Human Services.

  • Visit the Labcorp OnDemand® website to browse and purchase laboratory tests and create your Labcorp Patient™ account to view your results. All Labcorp OnDemand testing requires an order from an authorized healthcare professional. For your convenience, Labcorp OnDemand has contracted with independent professional entities (collectively, Providers) to deliver healthcare provider services. Visit a Labcorp location for sample collection; or, if using an at-home collection kit, collect your sample yourself. We’ll let you know when your results are ready and can be accessed through your Labcorp Patient™ account.